Diego Segura
@seguracardio.bsky.social
PhD 🩺🫀 Heart Failure | Prevention & Cardiovascular Risk | Cardiovascular Imaging | Pulmonary Hypertension | Lecturer📚
🚨 Ultraprocessed Foods & Their Association With Cardiometabolic Health:
Evidence, Gaps, & Opportunities: A Science Advisory From the @American_Heart
#CardioTwitter #MedTwitter #AHA #PositionPaper
buff.ly/x96lG8f
Evidence, Gaps, & Opportunities: A Science Advisory From the @American_Heart
#CardioTwitter #MedTwitter #AHA #PositionPaper
buff.ly/x96lG8f
August 10, 2025 at 6:00 PM
🚨 Ultraprocessed Foods & Their Association With Cardiometabolic Health:
Evidence, Gaps, & Opportunities: A Science Advisory From the @American_Heart
#CardioTwitter #MedTwitter #AHA #PositionPaper
buff.ly/x96lG8f
Evidence, Gaps, & Opportunities: A Science Advisory From the @American_Heart
#CardioTwitter #MedTwitter #AHA #PositionPaper
buff.ly/x96lG8f
Próximo lunes nuevo post📝
Subscríbete gratis para que te llegue la notificación
substack.com/@drdiegosegura
Subscríbete gratis para que te llegue la notificación
substack.com/@drdiegosegura
February 22, 2025 at 10:45 AM
Próximo lunes nuevo post📝
Subscríbete gratis para que te llegue la notificación
substack.com/@drdiegosegura
Subscríbete gratis para que te llegue la notificación
substack.com/@drdiegosegura
December 29, 2024 at 8:01 PM
Type 2 myocardial infarction: challenges in diagnosis & treatment
#StateOfTheArt #MI #EHJ
https://buff.ly/4iy25Qo
#StateOfTheArt #MI #EHJ
https://buff.ly/4iy25Qo
December 11, 2024 at 10:06 PM
Type 2 myocardial infarction: challenges in diagnosis & treatment
#StateOfTheArt #MI #EHJ
https://buff.ly/4iy25Qo
#StateOfTheArt #MI #EHJ
https://buff.ly/4iy25Qo
📌 Impact of #Aficamten on Disease & Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From #SEQUOIAHCM
https://buff.ly/3Oz3PuN
#OHCM #HCM
https://buff.ly/3Oz3PuN
#OHCM #HCM
December 1, 2024 at 8:22 PM
📌 Impact of #Aficamten on Disease & Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From #SEQUOIAHCM
https://buff.ly/3Oz3PuN
#OHCM #HCM
https://buff.ly/3Oz3PuN
#OHCM #HCM
📌Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
https://buff.ly/4ggaOEV
#PAH #HTP #PH
https://buff.ly/4ggaOEV
#PAH #HTP #PH
December 1, 2024 at 10:00 AM
📌Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
https://buff.ly/4ggaOEV
#PAH #HTP #PH
https://buff.ly/4ggaOEV
#PAH #HTP #PH
November 30, 2024 at 8:50 PM
📌 #Inclisiran administration potently & durably lowers LDL-C over an extended-term follow-up: the #ORION8 trial
https://buff.ly/4fNrpQh
https://buff.ly/4fNrpQh
November 29, 2024 at 5:08 PM
📌 #Inclisiran administration potently & durably lowers LDL-C over an extended-term follow-up: the #ORION8 trial
https://buff.ly/4fNrpQh
https://buff.ly/4fNrpQh
November 18, 2024 at 9:57 AM
November 18, 2024 at 9:57 AM
November 18, 2024 at 9:57 AM
November 18, 2024 at 9:57 AM